In female C57BL/6 mice, nicotine (0.25 and 2.50 μmol/kg, i.p.)treatment reduced the activation of NF-κB and colonic cytokine production, including IL-6, IL-17, and TNF, but failed to reduce the disease parameters in DSS colitis. This evidence concerns the gene NFKB1 and colitis.